Talat Imran
2021
In 2021, Talat Imran earned a total compensation of $11.8M as Chief Executive Officer at Rani Therapeutics Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $375,000 |
|---|---|
| Option Awards | $10,999,490 |
| Salary | $408,333 |
| Total | $11,782,823 |
Imran received $11M in option awards, accounting for 93% of the total pay in 2021.
Imran also received $375K in non-equity incentive plan and $408.3K in salary.
Rankings
In 2021, Talat Imran's compensation ranked 793rd out of 12,406 executives tracked by ExecPay. In other words, Imran earned more than 93.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 793 out of 12,406 | 94th |
Division Manufacturing | 259 out of 5,492 | 95th |
Major group Chemicals And Allied Products | 85 out of 2,368 | 96th |
Industry group Drugs | 72 out of 2,089 | 97th |
Industry Pharmaceutical Preparations | 45 out of 1,536 | 97th |
Source: SEC filing on April 13, 2022.
Imran's colleagues
We found three more compensation records of executives who worked with Talat Imran at Rani Therapeutics Holdings in 2021.